 | • レポートコード：GIR201113041 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、レーバー遺伝性視神経症治療薬の世界市場を調査対象にし、レーバー遺伝性視神経症治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（エラミプレチド、GS-011、IXC-201、KH-176、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Alkeus Pharmaceuticals, Inc.、Ixchel Pharma, LLC、Biovista Inc.、Stealth BioTherapeutics Inc.、GenSight Biologics S.A.、Spark Therapeutics, Inc.、Khondrion BV ・メーカー別販売量、売上、市場シェア ・レーバー遺伝性視神経症治療薬の地域別市場分析 ・レーバー遺伝性視神経症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・レーバー遺伝性視神経症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・レーバー遺伝性視神経症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・レーバー遺伝性視神経症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・レーバー遺伝性視神経症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・レーバー遺伝性視神経症治療薬の種類別市場規模2015-2020：エラミプレチド、GS-011、IXC-201、KH-176、その他 ・レーバー遺伝性視神経症治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・レーバー遺伝性視神経症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Leber’s Hereditary Optic Neuropathy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Leber’s Hereditary Optic Neuropathy Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Leber’s Hereditary Optic Neuropathy Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Leber’s Hereditary Optic Neuropathy Drug market has been segmented into
Elamipretide
GS-011
IXC-201
KH-176
Others
By Application, Leber’s Hereditary Optic Neuropathy Drug has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Leber’s Hereditary Optic Neuropathy Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Leber’s Hereditary Optic Neuropathy Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Leber’s Hereditary Optic Neuropathy Drug market.
The report offers in-depth assessment of the growth and other aspects of the Leber’s Hereditary Optic Neuropathy Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Leber’s Hereditary Optic Neuropathy Drug Market Share Analysis
Leber’s Hereditary Optic Neuropathy Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Leber’s Hereditary Optic Neuropathy Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Leber’s Hereditary Optic Neuropathy Drug sales, revenue and market share for each player covered in this report.
The major players covered in Leber’s Hereditary Optic Neuropathy Drug are:
Alkeus Pharmaceuticals, Inc.
Ixchel Pharma, LLC
Biovista Inc.
Stealth BioTherapeutics Inc.
GenSight Biologics S.A.
Spark Therapeutics, Inc.
Khondrion BV
Among other players domestic and global, Leber’s Hereditary Optic Neuropathy Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Leber’s Hereditary Optic Neuropathy Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Leber’s Hereditary Optic Neuropathy Drug, with price, sales, revenue and global market share of Leber’s Hereditary Optic Neuropathy Drug in 2018 and 2019.
Chapter 3, the Leber’s Hereditary Optic Neuropathy Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Leber’s Hereditary Optic Neuropathy Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Leber’s Hereditary Optic Neuropathy Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Leber’s Hereditary Optic Neuropathy Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Leber’s Hereditary Optic Neuropathy Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Elamipretide
1.2.3 GS-011
1.2.4 IXC-201
1.2.5 KH-176
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Leber’s Hereditary Optic Neuropathy Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Leber’s Hereditary Optic Neuropathy Drug Market
1.4.1 Global Leber’s Hereditary Optic Neuropathy Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Alkeus Pharmaceuticals, Inc.
2.1.1 Alkeus Pharmaceuticals, Inc. Details
2.1.2 Alkeus Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Alkeus Pharmaceuticals, Inc. SWOT Analysis
2.1.4 Alkeus Pharmaceuticals, Inc. Product and Services
2.1.5 Alkeus Pharmaceuticals, Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ixchel Pharma, LLC
2.2.1 Ixchel Pharma, LLC Details
2.2.2 Ixchel Pharma, LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ixchel Pharma, LLC SWOT Analysis
2.2.4 Ixchel Pharma, LLC Product and Services
2.2.5 Ixchel Pharma, LLC Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biovista Inc.
2.3.1 Biovista Inc. Details
2.3.2 Biovista Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biovista Inc. SWOT Analysis
2.3.4 Biovista Inc. Product and Services
2.3.5 Biovista Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Stealth BioTherapeutics Inc.
2.4.1 Stealth BioTherapeutics Inc. Details
2.4.2 Stealth BioTherapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Stealth BioTherapeutics Inc. SWOT Analysis
2.4.4 Stealth BioTherapeutics Inc. Product and Services
2.4.5 Stealth BioTherapeutics Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GenSight Biologics S.A.
2.5.1 GenSight Biologics S.A. Details
2.5.2 GenSight Biologics S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GenSight Biologics S.A. SWOT Analysis
2.5.4 GenSight Biologics S.A. Product and Services
2.5.5 GenSight Biologics S.A. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Spark Therapeutics, Inc.
2.6.1 Spark Therapeutics, Inc. Details
2.6.2 Spark Therapeutics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Spark Therapeutics, Inc. SWOT Analysis
2.6.4 Spark Therapeutics, Inc. Product and Services
2.6.5 Spark Therapeutics, Inc. Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Khondrion BV
2.7.1 Khondrion BV Details
2.7.2 Khondrion BV Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Khondrion BV SWOT Analysis
2.7.4 Khondrion BV Product and Services
2.7.5 Khondrion BV Leber’s Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Leber’s Hereditary Optic Neuropathy Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Leber’s Hereditary Optic Neuropathy Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
4.3 Europe Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
4.5 South America Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Leber’s Hereditary Optic Neuropathy Drug Sales, Revenue and Market Share by Country
5.1.1 North America Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
5.3 Canada Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Leber’s Hereditary Optic Neuropathy Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
6.3 UK Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
6.4 France Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
6.5 Russia Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
6.6 Italy Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
7.3 Japan Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
7.4 Korea Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
7.5 India Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
7.7 Australia Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Leber’s Hereditary Optic Neuropathy Drug Sales, Revenue and Market Share by Country
8.1.1 South America Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Leber’s Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales and Market Share by Type (2015-2020)
10.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Leber’s Hereditary Optic Neuropathy Drug Price by Type (2015-2020)
11 Global Leber’s Hereditary Optic Neuropathy Drug Market Segment by Application
11.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales Market Share by Application (2015-2020)
11.2 Global Leber’s Hereditary Optic Neuropathy Drug Revenue Market Share by Application (2015-2020)
11.3 Global Leber’s Hereditary Optic Neuropathy Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Leber’s Hereditary Optic Neuropathy Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Leber’s Hereditary Optic Neuropathy Drug Market Forecast (2021-2025)
12.2.2 Europe Leber’s Hereditary Optic Neuropathy Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Leber’s Hereditary Optic Neuropathy Drug Market Forecast (2021-2025)
12.2.4 South America Leber’s Hereditary Optic Neuropathy Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Leber’s Hereditary Optic Neuropathy Drug Market Forecast (2021-2025)
12.3 Leber’s Hereditary Optic Neuropathy Drug Market Forecast by Type (2021-2025)
12.3.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Leber’s Hereditary Optic Neuropathy Drug Market Share Forecast by Type (2021-2025)
12.4 Leber’s Hereditary Optic Neuropathy Drug Market Forecast by Application (2021-2025)
12.4.1 Global Leber’s Hereditary Optic Neuropathy Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Leber’s Hereditary Optic Neuropathy Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Leber's Hereditary Optic Neuropathy Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Leber's Hereditary Optic Neuropathy Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Leber's Hereditary Optic Neuropathy Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Alkeus Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Major Business
Table 9. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Total Revenue (USD Million) (2018-2019)
Table 10. Alkeus Pharmaceuticals, Inc. SWOT Analysis
Table 11. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 12. Alkeus Pharmaceuticals, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Ixchel Pharma, LLC Basic Information, Manufacturing Base and Competitors
Table 14. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Major Business
Table 15. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Total Revenue (USD Million) (2018-2019)
Table 16. Ixchel Pharma, LLC SWOT Analysis
Table 17. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 18. Ixchel Pharma, LLC Leber's Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biovista Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Major Business
Table 21. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Total Revenue (USD Million) (2018-2019)
Table 22. Biovista Inc. SWOT Analysis
Table 23. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 24. Biovista Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Stealth BioTherapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 26. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Major Business
Table 27. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Total Revenue (USD Million) (2018-2019)
Table 28. Stealth BioTherapeutics Inc. SWOT Analysis
Table 29. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 30. Stealth BioTherapeutics Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GenSight Biologics S.A. Basic Information, Manufacturing Base and Competitors
Table 32. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Major Business
Table 33. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Total Revenue (USD Million) (2018-2019)
Table 34. GenSight Biologics S.A. SWOT Analysis
Table 35. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 36. GenSight Biologics S.A. Leber's Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Spark Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Major Business
Table 39. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Total Revenue (USD Million) (2018-2019)
Table 40. Spark Therapeutics, Inc. SWOT Analysis
Table 41. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 42. Spark Therapeutics, Inc. Leber's Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Khondrion BV Basic Information, Manufacturing Base and Competitors
Table 44. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Major Business
Table 45. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Total Revenue (USD Million) (2018-2019)
Table 46. Khondrion BV SWOT Analysis
Table 47. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Product and Services
Table 48. Khondrion BV Leber's Hereditary Optic Neuropathy Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Leber's Hereditary Optic Neuropathy Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 50. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Leber's Hereditary Optic Neuropathy Drug Sales by Regions (2015-2020) (K Pcs)
Table 52. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Regions (2015-2020)
Table 53. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Leber's Hereditary Optic Neuropathy Drug Sales by Countries (2015-2020) (K Pcs)
Table 55. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries (2015-2020)
Table 56. North America Leber's Hereditary Optic Neuropathy Drug Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries (2015-2020)
Table 58. Europe Leber's Hereditary Optic Neuropathy Drug Sales by Countries (2015-2020) (K Pcs)
Table 59. Europe Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries (2015-2020)
Table 60. Europe Leber's Hereditary Optic Neuropathy Drug Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales by Regions (2015-2020) (K Pcs)
Table 62. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Leber's Hereditary Optic Neuropathy Drug Sales by Countries (2015-2020) (K Pcs)
Table 65. South America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries (2015-2020)
Table 66. South America Leber's Hereditary Optic Neuropathy Drug Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales by Countries (2015-2020) (K Pcs)
Table 69. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries (2015-2020)
Table 72. Global Leber's Hereditary Optic Neuropathy Drug Sales by Type (2015-2020) (K Pcs)
Table 73. Global Leber's Hereditary Optic Neuropathy Drug Sales Share by Type (2015-2020)
Table 74. Global Leber's Hereditary Optic Neuropathy Drug Revenue by Type (2015-2020) (USD Million)
Table 75. Global Leber's Hereditary Optic Neuropathy Drug Revenue Share by Type (2015-2020)
Table 76. Global Leber's Hereditary Optic Neuropathy Drug Sales by Application (2015-2020) (K Pcs)
Table 77. Global Leber's Hereditary Optic Neuropathy Drug Sales Share by Application (2015-2020)
Table 78. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Regions (2021-2025) (K Pcs)
Table 79. Global Leber's Hereditary Optic Neuropathy Drug Market Share Forecast by Regions (2021-2025)
Table 80. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Type (2021-2025) (K Pcs)
Table 81. Global Leber's Hereditary Optic Neuropathy Drug Market Share Forecast by Type (2021-2025)
Table 82. Global Leber's Hereditary Optic Neuropathy Drug Sales Forecast by Application (2021-2025)
Table 83. Global Leber's Hereditary Optic Neuropathy Drug Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Leber's Hereditary Optic Neuropathy Drug Picture
Figure 2. Global Sales Market Share of Leber's Hereditary Optic Neuropathy Drug by Type in 2019
Figure 3. Elamipretide Picture
Figure 4. GS-011 Picture
Figure 5. IXC-201 Picture
Figure 6. KH-176 Picture
Figure 7. Others Picture
Figure 8. Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Leber's Hereditary Optic Neuropathy Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Leber's Hereditary Optic Neuropathy Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Leber's Hereditary Optic Neuropathy Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Leber's Hereditary Optic Neuropathy Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Regions in 2018
Figure 41. North America Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries in 2018
Figure 49. North America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries in 2018
Figure 51. United States Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Regions 2019
Figure 65. China Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries in 2019
Figure 72. South America Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Leber's Hereditary Optic Neuropathy Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Leber's Hereditary Optic Neuropathy Drug Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Leber's Hereditary Optic Neuropathy Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Leber's Hereditary Optic Neuropathy Drug Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Leber's Hereditary Optic Neuropathy Drug Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Leber's Hereditary Optic Neuropathy Drug Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Leber's Hereditary Optic Neuropathy Drug Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Leber's Hereditary Optic Neuropathy Drug Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
視神経症治療薬の世界市場 2020年 Market Overview The global Optic Neuropathy Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Optic Neuropathy Drug m…- 神経障害スクリーニング装置の世界市場 2020年 Market Overview The global Neuropathy Screening Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Neuropathy Scree…
- 遺伝性血管浮腫治療の世界市場 2020年 Market Overview The global Hereditary Angioedema Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hereditary An…
- 糖尿病性末梢神経障害治療の世界市場 2020年 Market Overview The global Diabetic Peripheral Neuropathy Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diab…
- 化学療法誘発末梢神経障害治療の世界市場 2020年 Market Overview The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…